washington post medicare

News

Medicare, weight loss drugs

Medicare, Medicaid plan to experiment with covering weight loss drugs

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially benefiting millions of Americans struggling with obesity.

Reuters on MSN · 4d

US plans Medicare, Medicaid coverage for weight-loss drugs, Washington Post reports

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington Post reported on Friday, citing documents from the Centers for Medicare and Medicaid Services.

Gizmodo · 4d

Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity medications.

4don MSN

A Medicare experiment could change who gets Ozempic

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

Becker's ASC7h

CMS pilot could ease GLP-1 access for Medicare, Medicaid patients

GLP‑1 receptor agonists are widely recognized for aiding weight loss and controlling blood sugar, but access remains limited — especially for Medicare and Medicaid patients. That might change with a ...

4don MSN

Trump’s Weight-Loss Experiment Could Aid Lilly, Novo. Cost Is Still a Problem.

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.

12d

UnitedHealth says it is under a federal investigation and cooperating

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results